Silo Pharma Files 8-K

Ticker: SILO · Form: 8-K · Filed: Aug 5, 2025 · CIK: 1514183

Silo Pharma, Inc. 8-K Filing Summary
FieldDetail
CompanySilo Pharma, Inc. (SILO)
Form Type8-K
Filed DateAug 5, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-actions, filing

TL;DR

Silo Pharma filed an 8-K on Aug 4, 2025, with no major business updates but historical company name changes noted.

AI Summary

Silo Pharma, Inc. filed an 8-K on August 5, 2025, reporting other events and financial statements. The company, formerly known as Uppercut Brands, Inc., Gold Swap Inc, and Point Capital, Inc., is incorporated in Nevada and headquartered in Sarasota, Florida.

Why It Matters

This filing provides an update on Silo Pharma's corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.

Risk Assessment

Risk Level: low — The filing is a routine 8-K reporting other events and financial statements without disclosing significant new business developments or financial risks.

Key Players & Entities

  • Silo Pharma, Inc. (company) — Registrant
  • August 4, 2025 (date) — Date of earliest event reported
  • August 5, 2025 (date) — Date of report
  • Nevada (jurisdiction) — State of incorporation
  • Sarasota, FL (location) — Principal executive offices address
  • Uppercut Brands, Inc. (company) — Former company name
  • Gold Swap Inc (company) — Former company name
  • Point Capital, Inc. (company) — Former company name

FAQ

What is the primary purpose of this 8-K filing for Silo Pharma, Inc.?

The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of August 4, 2025.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on August 4, 2025.

What is Silo Pharma, Inc.'s state of incorporation?

Silo Pharma, Inc. is incorporated in Nevada.

What are some of Silo Pharma, Inc.'s former company names?

Silo Pharma, Inc. was formerly known as Uppercut Brands, Inc., Point Capital, Inc., and Gold Swap Inc.

Where are Silo Pharma, Inc.'s principal executive offices located?

Silo Pharma, Inc.'s principal executive offices are located at 677 N. Washington Boulevard, Sarasota, FL 34236.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding Silo Pharma, Inc. (SILO).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.